Afidro

What Afidro does

Afidro (Asociación de Laboratorios Farmacéuticos de Investigación y Desarrollo) is a Colombian non-profit industry association founded circa 1962, headquartered in Bogotá, that represents 29 pharmaceutical research and development laboratories from around the world operating in Colombia. The association's core function is collective advocacy on healthcare policy, drug regulation, and patient access to innovative medicines, working directly with the Ministry of Health, the Ministry of Commerce, Industry and Tourism, INVIMA (Colombia's drug regulator), and IETS (the health-technology assessment institute). Its product portfolio is centered on public-facing campaigns and data/educational tools rather than commercial goods: the Visor Farmacéutico (a Power BI dashboard consolidating key pharmaceutical-sector indicators), the AFISUMMIT annual conference, Vivir + (a prevention-and-health-promotion campaign), Confianza Sanitaria (a regulatory-reform initiative arguing that regulatory reliance could reduce evaluation costs by up to 90%), and educational programs such as Tu ABC de la Salud, Ciencia para la Vida, Absurdometrías, and Inmunes a la Desinformación.

The business model is that of a member-funded trade association: revenue derives from dues paid by the 29 member companies (which include global pharma R&D firms such as AstraZeneca), with no publicly disclosed pricing or external funding rounds. Afidro employs 11-50 staff across two Bogotá offices (Av. Carrera 19 No. 118-30 and Carrera 14 No 99-33) and operates within a single domestic market (Colombia), although its analytical output now extends Latin America–wide via the WAIT Indicator report. Distribution is relationship-driven rather than channel-driven: Afidro's "channel" to market impact is government relations, coalition-building with peers such as Asinfar and Así Vamos en Salud, and sustained public communications through its website, newsletter, and social media. The operating context in 2026 is defined by a structural healthcare-system crisis — a reported budget deficit exceeding $10.1 trillion pesos for 2026 and sector debt of $4.42 trillion pesos — which positions Afidro's regulatory-reform and financing-advocacy agenda at the center of its strategic activity.

Name

Afidro

Legal name

Asociación de Laboratorios Farmacéuticos de Investigación y Desarrollo

Website

https://afidro.org

Company type

Private

Founded year

1962

Operating status

Operating

Headcount range

11–50 employees

Short description

Afidro is a Colombian non-profit industry association, founded circa 1962, that represents 29 multinational pharmaceutical research and development companies operating in Colombia, advocating for healthcare policy reform, regulatory modernization, and patient access to innovative medicines.

Ownership category

akta.pro rank

Headquarters

HQ city

Bogotá

HQ country

Colombia

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Distribution channels1 record

Marketing channels4 records

Core offering

Afidro is a non-profit industry association representing 29 pharmaceutical research and development laboratories operating in Colombia. Its core work includes collective advocacy and policy engagement on behalf of member companies, regulatory reform initiatives (Confianza Sanitaria), an industry data visualization tool (Visor Farmacéutico), an annual industry summit (AFISUMMIT), a clinical studies information service, and public-facing health education and prevention campaigns (Vivir +, Tu ABC De la Salud, Inmunes a la Desinformación).

Product overview

AFIDRO (Asociación de Laboratorios Farmacéuticos de Investigación y Desarrollo) is a pharmaceutical industry association with 64 years of existence, representing 29 pharmaceutical companies engaged in research and development. Rather than offering a single unified product, AFIDRO operates a portfolio of public health initiatives and data tools. The core offerings include the Visor Farmacéutico (a data visualization tool for pharmaceutical sector indicators), the Vivir+ health promotion campaign, and various educational initiatives like Tu ABC De la Salud and Absurdometrías. The association also runs advocacy programs including the Confianza Sanitaria regulatory reform initiative and the annual AFISUMMIT conference. These initiatives collectively aim to improve the Colombian healthcare system, promote innovation, and ensure patient access to medications.

Differentiator

Problem solved

Functional benefit

Brands

• Vivir +: Promotion and prevention campaign seeking for Colombians to understand the importance of being managers of their own health.
• Inmunes a la Desinformación
• Ciencia para la Vida
• Absurdometrías
• Confianza Sanitaria
• AFISUMMIT
• Visor Farmacéutico
• Tu ABC de la Salud

Products and services

• Visor Farmacéutico A query and visualization tool, built on Microsoft Power BI, that consolidates key pharmaceutical sector indicators for stakeholders to access and analyze data about the Colombian pharmaceutical market.
• AFISUMMIT Annual pharmaceutical and healthcare industry summit organized by Afidro, focused on action, future trends, and innovation for stakeholders in the Colombian pharmaceutical sector.
• Consulta Estudios Clínicos An online information service that provides stakeholders with the status of clinical studies conducted in Colombia, supporting analysis of patient-relevant health challenges.

Quantifiable outcome

• Regulatory confidence could reduce innovative medicine evaluation costs by up to 90%
• +1 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Six partnerships are on record, tiered core.

• Abelardo de la Espriella (President-elect of Colombia)coreStrategic or Co-development Partner · 21 June 2026Afidro congratulated the president-elect and reaffirmed its commitment to the health of all Colombians. This represents a constructive engagement with the new government to address the healthcare system crisis.
• AsinfarcoreStrategic or Co-development PartnerIndustry group that, together with Afidro, argues that the bottleneck in the healthcare system is not production capacity, with domestic manufacturers able to supply roughly 80% of needed units, but rather poor planning, lack of traceability, unclear rules, and systemic underfunding.
• Así Vamos en SaludcoreStrategic or Co-development PartnerHealth policy organization that warns about financing gaps in the healthcare system. Afidro works with this organization to analyze healthcare system deficits and financing issues.
• ProesacoreStrategic or Co-development PartnerTechnical organization whose priorities are measured against Afidro's proposals for addressing the healthcare crisis, including adequate financing, regulatory reform, faster medication access, and technological modernization.
• InvimacoreOthersInstituto Nacional de Vigilancia de Medicamentos y Alimentos - Colombia's regulatory body responsible for drug safety and efficacy. Afidro works with Invima on regulatory confidence initiatives and pharmacovigilance.
• IETS (Instituto de Evaluación de Tecnología en Salud)coreOthersInstitute of Health Technology Assessment that Afidro engages with on issues related to healthcare technology evaluation and innovation.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Regional players

• CILFA: Cámara Industrial de Laboratorios Farmacéuticos Argentinos—Argentine pharma industry chamber. Comparable Southern Cone peer operating in a similarly complex healthcare reform environment.
• ALAFARPE: Asociación Nacional de Laboratorios Farmacéuticos del Perú—Peruvian pharma industry association. Andean-region peer with comparable structure and advocacy focus.
• InterFARMA: Associação da Indústria Farmacêutica de Pesquisa—Brazilian pharma R&D industry association. Closest large-scale regional peer; same trade association model serving innovative pharma members in a single Latin American market.
• CANIFARMA: Cámara Nacional de la Industria Farmacéutica—Mexican national pharma industry chamber. Comparable single-country trade association model serving multinational and domestic pharma R&D companies.

Broad incumbents

• IFPMA: International Federation of Pharmaceutical Manufacturers & Associations—global R&D pharma federation headquartered in Geneva. Comparable mission and member profile, operating at global scale.
• EFPIA: European Federation of Pharmaceutical Industries and Associations—EU pharma R&D trade association. Comparable advocacy mandate on regulatory reform, IP, and market access but operating at European scale.
• PhRMA: Pharmaceutical Research and Manufacturers of America—largest US pharma R&D association with global influence. Same structural model (industry-funded R&D advocacy) but vastly greater scale and a US regulatory focus.

Direct peers

• FIFARMA: Federación Latinoamericana de la Industria Farmacéutica—regional federation of national pharmaceutical industry associations including Afidro. Most directly comparable peer given shared Latin American scope and R&D industry focus.
• ALIFAR: Asociación Latinoamericana de Industrias Farmacéuticas—Latin American pharmaceutical industry association serving a comparable membership of R&D-focused companies across multiple jurisdictions.

Others

• Asinfar: Asociación de Industrias Farmacéuticas Colombianas—domestic Colombian pharma industry association representing local manufacturers. Operates alongside Afidro in the same country (per disclosed Afidro partnership) but focuses on national manufacturers rather than multinational R&D.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/afidro_colombia
• YouTubeyoutube.com/channel/UCeHvxADXQeBtGx7-DwxB3qQ
• Facebookfacebook.com/afidroloImportantedelavida
• LinkedInlinkedin.com/company/afidro-colombia

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Afidro